Delivery Order SPE2DR25D2206-SPE2DR26F9PB8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,333.83 to AmerisourceBergen Drug Corp for Fentanyl 100 micrograms per 2 milliliter vials on January 6, 2026, with an ultimate completion date of January 7, 2026. This is a firm fixed-price, non-set-aside contract for delivery to the company's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,218.24 to AmerisourceBergen Drug Corp for the supply of Fentanyl 100 micrograms per 2 milliliter vials on January 28, 2026, with completion targeted for January 29, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price terms and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Fentanyl 100 micrograms per 2 milliliter vials at a ceiling value of $1,345.37. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for ultimate completion by December 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Fentanyl 100 micrograms per 2 milliliters in 2 milliliter vials. The contract is a firm fixed-price delivery order with a ceiling value of $1,774.26 and an ultimate completion date of September 3, 2025. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award was made through open competition with no...
- The U.S. Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,258.56 for Fentanyl 100 MCG/2 ML vials on September 9, 2025, with completion targeted for September 10, 2025. This competitively awarded, firm fixed-price contract requires no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,309.28 to AmerisourceBergen Drug Corp for the supply of Fentanyl 100 mcg/2 mL vials on July 14, 2025, with an ultimate completion date of July 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to a qualified vendor. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Fentanyl 100 MCG/2 ML Vial 2ML, valued at $1,667.43. This competitively awarded, firm fixed-price delivery order was issued on July 21, 2025, with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. This contract represents a child order under...
- The Defense Logistics Agency awarded a delivery order valued at $2,448.68 to AmerisourceBergen Drug Corp for the supply of Fentanyl 100 micrograms per 2 milliliter vials on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- This delivery order awards AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, a contract valued at $1,658.68 for the supply of Fentanyl 100 micrograms/2 milliliters. The contract represents a firm fixed-price delivery order under a non-competitive set-aside, awarded by the Medical Supply Chain division of the Defense Logistics Agency on July 14, 2025, with an ultimate completion date of August 8, 2025. The place of performance is located in...
- The Defense Logistics Agency awarded a $1,162.00 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Fentanyl 2,500 micrograms per 50 milliliter vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 28, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9PB8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerSourceBergen Drug Corp on February 3, 2026, for the supply of Fentanyl 100 micrograms/2 milliliters in 2-milliliter vials with a ceiling value of $1,058.50. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of February 4, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order was issued under AmerSourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerSourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company operates as a subsidiary of Cencora, Inc. (doing business as AmerSourceBergen), which holds the primary IDC with DLA. Both entities compete on a full and open basis for federal contracts and have demonstrated capability in efficiently fulfilling government requirements for essential pharmaceutical and medical commodities across multiple therapeutic domains, including pain management medications such as fentanyl needed by military treatment facilities and federal healthcare institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 2/2/26 |